Merck and HAPPYneuron partner to include cognitive remediation program in Multiple Sclerosis e‑Health Solution

Mer­ck KGaA In Deal With HAP­PYneu­ron To Offer E‑Health Solu­tion For MS Patients (Nas­daq): “Ger­man drug mak­er Mer­ck KGaA (MKGAY.PK) announced Mon­day that it has entered into an agree­ment with HAP­PYneu­ron, a sub­sidiary of SBT Group of France, in which Mer­ck will receive an exclu­sive license to the com­pa­ny’s cog­ni­tive reme­di­a­tion train­ing pro­gram for people…

Read More

Got Brain? Investing in Our Most Precious Asset in 2013

Open a week­end New York Times or Wall Street Jour­nal and you’ll find a whole sec­tion with detailed infor­ma­tion and advice for indi­vid­u­als look­ing to invest wise­ly. What you will not find, how­ev­er, is com­pa­ra­ble infor­ma­tion and advice for invest­ing in your most impor­tant asset of all: your brain. Pre­cise­ly because it (usu­al­ly) does its…

Read More